Avinger (AVGR) Sets New 12-Month Low at $6.34
Avinger Inc (NASDAQ:AVGR)’s share price reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as $6.34 and last traded at $6.35, with a volume of 114696 shares traded. The stock had previously closed at $7.20.
Separately, Zacks Investment Research cut shares of Avinger from a “buy” rating to a “hold” rating in a research report on Thursday, January 11th. Four equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $105.00.
The stock has a market cap of $198.70 and a PE ratio of -0.07.
In other Avinger news, insider John B. Ph D. Md Simpson sold 1,074,130 shares of the stock in a transaction dated Wednesday, November 15th. The shares were sold at an average price of $0.25, for a total value of $268,532.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Chairman John B. Ph D. Md Simpson sold 454,584 shares of the stock in a transaction dated Monday, November 13th. The shares were sold at an average price of $0.27, for a total transaction of $122,737.68. The disclosure for this sale can be found here. 17.00% of the stock is currently owned by company insiders.
An institutional investor recently bought a new position in Avinger stock. AWM Investment Company Inc. acquired a new stake in Avinger Inc (NASDAQ:AVGR) in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm acquired 1,150,000 shares of the medical device company’s stock, valued at approximately $516,000. AWM Investment Company Inc. owned about 4.81% of Avinger as of its most recent filing with the SEC. 3.75% of the stock is owned by institutional investors and hedge funds.
WARNING: This report was posted by Watch List News and is the property of of Watch List News. If you are viewing this report on another website, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this report can be accessed at https://www.watchlistnews.com/avinger-avgr-sets-new-12-month-low-at-6-34/1838391.html.
Avinger Company Profile
Avinger, Inc is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Company focuses on introducing products based on its lumivascular platform, which is an intravascular image-guided system.
Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.